癫痫诊疗新进展
New Advances in the Diagnosis and Treatment of Epilepsy
DOI: 10.12677/acm.2025.1561793, PDF,   
作者: 赵雨薇：赣南医科大学基础医学院，江西 赣州；薛齐兴, 秦奕琳：赣南医科大学临床医学院，江西 赣州；黄玉珊*：赣南医科大学第一附属医院循证医学研究中心，江西 赣州
关键词: 癫痫；癫痫发作；抗癫痫药物；癫痫手术；神经调控；生酮饮食；Epilepsy； Seizuer； Anti-Epileptic Drug； Epilepsy Surgery； Neuromodulation； Ketogenic Diet
摘要: 癫痫是一种影响着各个年龄段的严重神经系统疾病，全球有超过7000万的人受到影响。针对癫痫的治疗方法，最主要的手段是药物治疗，对于耐药性癫痫，癫痫手术、神经调控技术和生酮饮食等治疗方法也得到应用。抗癫痫新靶点的研究发现和新型药物的开发、病灶定位精度的提升和手术治疗技术的进步、无创技术的应用、对生酮饮食治疗机制的研究和创新正在推动着癫痫治疗向着全面和精准的方向进步和发展。本文就癫痫的部分诊疗手段和机制及新进展进行综述。
Abstract: Epilepsy is a serious neurological disorder that affects people of all ages and affects more than 70 million people worldwide. The mainstay of treatment for epilepsy is pharmacological therapy, and for drug-resistant epilepsy, treatments such as epilepsy surgery, neuromodulation techniques, and ketogenic diets have also been applied. The discovery of new antiepileptic targets and the development of novel drugs, the improvement of lesion localisation accuracy and the advancement of surgical treatment techniques, the application of non-invasive techniques, and the research and innovation on the therapeutic mechanism of the ketogenic diet are driving epilepsy treatment to progress and develop in the direction of comprehensiveness and precision. This article provides an overview of some of the diagnostic and therapeutic tools and mechanisms of epilepsy and new advances.
文章引用：赵雨薇, 薛齐兴, 秦奕琳, 黄玉珊. 癫痫诊疗新进展[J]. 临床医学进展, 2025, 15(6): 815-822. https://doi.org/10.12677/acm.2025.1561793

参考文献

[1] Qin, B., Wu, X. and Xu, J. (2014) Discussion on the Practical Clinical Definition of Epilepsy in 2014. Chinese Medical Journal, 94, 2161-2164.
[2] Falco-Walter, J. (2020) Epilepsy—Definition, Classification, Pathophysiology, and Epidemiology. Seminars in Neurology, 40, 617-623. [Google Scholar] [CrossRef] [PubMed]
[3] 王群, 翁诗雯, 杨华俊, 单伟. 回眸2023——癫痫诊疗研究进展[J]. 中华神经科杂志, 2024, 57(10): 1037-1044.
[4] Waris, A., Siraj, M., Khan, A., Lin, J., Asim, M. and Alhumaydh, F.A. (2024) A Comprehensive Overview of the Current Status and Advancements in Various Treatment Strategies against Epilepsy. ACS Pharmacology & Translational Science, 7, 3729-3757. [Google Scholar] [CrossRef] [PubMed]
[5] 朱翠, 刘廷涛, 刘学伍. 抗癫痫发作药物联合治疗的研究进展[J]. 中华神经科杂志, 2022, 55(12): 1442-1446.
[6] Pong, A.W., Xu, K.J. and Klein, P. (2023) Recent Advances in Pharmacotherapy for Epilepsy. Current Opinion in Neurology, 36, 77-85. [Google Scholar] [CrossRef] [PubMed]
[7] Guerreiro, C.A.M. (2016) Epilepsy. Indian Journal of Medical Research, 144, 657-660. [Google Scholar] [CrossRef] [PubMed]
[8] Kwan, P. and Brodie, M.J. (2000) Early Identification of Refractory Epilepsy. New England Journal of Medicine, 342, 314-319. [Google Scholar] [CrossRef] [PubMed]
[9] Kwan, P., Arzimanoglou, A., Berg, A.T., Brodie, M.J., Allen Hauser, W., Mathern, G., et al. (2010) Definition of Drug Resistant Epilepsy: Consensus Proposal by the Ad Hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 51, 1069-1077. [Google Scholar] [CrossRef] [PubMed]
[10] Thijs, R.D., Surges, R., O’Brien, T.J. and Sander, J.W. (2019) Epilepsy in Adults. The Lancet, 393, 689-701. [Google Scholar] [CrossRef] [PubMed]
[11] Semah, F., Picot, M.-C., Adam, C., Broglin, D., Arzimanoglou, A., Bazin, B., et al. (1998) Is the Underlying Cause of Epilepsy a Major Prognostic Factor for Recurrence? Neurology, 51, 1256-1262. [Google Scholar] [CrossRef] [PubMed]
[12] Jobst, B.C. and Cascino, G.D. (2015) Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy. JAMA, 313, 285-293. [Google Scholar] [CrossRef] [PubMed]
[13] Wiebe, S., Blume, W.T., Girvin, J.P. and Eliasziw, M. (2001) A Randomized, Controlled Trial of Surgery for Temporal-Lobe Epilepsy. New England Journal of Medicine, 345, 311-318. [Google Scholar] [CrossRef] [PubMed]
[14] Duncan, J.S., Winston, G.P., Koepp, M.J. and Ourselin, S. (2016) Brain Imaging in the Assessment for Epilepsy Surgery. The Lancet Neurology, 15, 420-433. [Google Scholar] [CrossRef] [PubMed]
[15] Zijlmans, M., Worrell, G.A., Dümpelmann, M., Stieglitz, T., Barborica, A., Heers, M., et al. (2017) How to Record High‐frequency Oscillations in Epilepsy: A Practical Guideline. Epilepsia, 58, 1305-1315. [Google Scholar] [CrossRef] [PubMed]
[16] Wicks, R.T., Jermakowicz, W.J., Jagid, J.R., Couture, D.E., Willie, J.T., Laxton, A.W., et al. (2016) Laser Interstitial Thermal Therapy for Mesial Temporal Lobe Epilepsy. Neurosurgery, 79, S83-S91. [Google Scholar] [CrossRef] [PubMed]
[17] Cossu, M., Cardinale, F., Casaceli, G., Castana, L., Consales, A., D’Orio, P., et al. (2017) Stereo-EEG-Guided Radiofrequency Thermocoagulations. Epilepsia, 58, 66-72. [Google Scholar] [CrossRef] [PubMed]
[18] Guénot, M., Isnard, J., Catenoix, H., Mauguière, F. and Sindou, M. (2011) SEEG-Guided Rf-Thermocoagulation of Epileptic Foci: A Therapeutic Alternative for Drug-Resistant Non-Operable Partial Epilepsies. In: Pickard, J.D., et al., Eds., Advances and Technical Standards in Neurosurgery, Springer Vienna, 61-78. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, J., Xie, H. and Yang, A. (2025) Neuromodulation: Clinical Advances and Future Perspectives. Chinese Journal of Contemporary Neurology and Neurosurgery, 25, 1-10.
[20] Yan, H., Toyota, E., Anderson, M., Abel, T.J., Donner, E., Kalia, S.K., et al. (2019) A Systematic Review of Deep Brain Stimulation for the Treatment of Drug-Resistant Epilepsy in Childhood. Journal of Neurosurgery: Pediatrics, 23, 274-284. [Google Scholar] [CrossRef] [PubMed]
[21] Gouveia, F.V., Warsi, N.M., Suresh, H., Matin, R. and Ibrahim, G.M. (2024) Neurostimulation Treatments for Epilepsy: Deep Brain Stimulation, Responsive Neurostimulation and Vagus Nerve Stimulation. Neurotherapeutics, 21, e00308. [Google Scholar] [CrossRef] [PubMed]
[22] Bouwens van der Vlis, T.A.M., Schijns, O.E.M.G., Schaper, F.L.W.V.J., Hoogland, G., Kubben, P., Wagner, L., et al. (2019) Deep Brain Stimulation of the Anterior Nucleus of the Thalamus for Drug-Resistant Epilepsy. Neurosurgical Review, 42, 287-296. [Google Scholar] [CrossRef] [PubMed]
[23] Warsi, N.M., Yan, H., Suresh, H., Wong, S.M., Arski, O.N., Gorodetsky, C., et al. (2022) The Anterior and Centromedian Thalamus: Anatomy, Function, and Dysfunction in Epilepsy. Epilepsy Research, 182, Article 106913. [Google Scholar] [CrossRef] [PubMed]
[24] Valero-Cabré, A., Amengual, J.L., Stengel, C., Pascual-Leone, A. and Coubard, O.A. (2017) Transcranial Magnetic Stimulation in Basic and Clinical Neuroscience: A Comprehensive Review of Fundamental Principles and Novel Insights. Neuroscience & Biobehavioral Reviews, 83, 381-404. [Google Scholar] [CrossRef] [PubMed]
[25] Pang, S., D’Ambrosio, S., Battaglia, G., Jiménez-Jiménez, D., Perulli, M., Silvennoinen, K., et al. (2022) The Impact of Transcranial Magnetic Stimulation (TMS) on Seizure Course in People with and without Epilepsy. Clinical Neurophysiology Practice, 7, 174-182. [Google Scholar] [CrossRef] [PubMed]
[26] Binnie, C.D. (2000) Vagus Nerve Stimulation for Epilepsy: A Review. Seizure, 9, 161-169. [Google Scholar] [CrossRef] [PubMed]
[27] Ellrich, J. (2019) Transcutaneous Auricular Vagus Nerve Stimulation. Journal of Clinical Neurophysiology, 36, 437-442. [Google Scholar] [CrossRef] [PubMed]
[28] Yang, J. and Phi, J.H. (2019) The Present and Future of Vagus Nerve Stimulation. Journal of Korean Neurosurgical Society, 62, 344-352. [Google Scholar] [CrossRef] [PubMed]
[29] Sills, G.J. and Rogawski, M.A. (2020) Mechanisms of Action of Currently Used Antiseizure Drugs. Neuropharmacology, 168, Article 107966. [Google Scholar] [CrossRef] [PubMed]
[30] Haas, H. and Panula, P. (2003) The Role of Histamine and the Tuberomamillary Nucleus in the Nervous System. Nature Reviews Neuroscience, 4, 121-130. [Google Scholar] [CrossRef] [PubMed]
[31] Lamb, Y.N. (2020) Pitolisant: A Review in Narcolepsy with or without Cataplexy. CNS Drugs, 34, 207-218. [Google Scholar] [CrossRef] [PubMed]
[32] Schwartz, J. (2011) The Histamine H3 Receptor: From Discovery to Clinical Trials with Pitolisant. British Journal of Pharmacology, 163, 713-721. [Google Scholar] [CrossRef] [PubMed]
[33] Beheshti, S. and Wesal, M.W. (2022) Anticonvulsant Activity of the Histamine H3 Receptor Inverse Agonist Pitolisant in an Electrical Kindling Model of Epilepsy. Neuroscience Letters, 782, Article 136685. [Google Scholar] [CrossRef] [PubMed]
[34] Kasteleijn-Nolst Trenité, D., Parain, D., Genton, P., Masnou, P., Schwartz, J. and Hirsch, E. (2013) Efficacy of the Histamine 3 Receptor (H3R) Antagonist Pitolisant (Formerly Known as Tiprolisant; BF2.649) in Epilepsy: Dose-Dependent Effects in the Human Photosensitivity Model. Epilepsy & Behavior, 28, 66-70. [Google Scholar] [CrossRef] [PubMed]
[35] Collart Dutilleul, P., Ryvlin, P., Kahane, P., Vercueil, L., Semah, F., Biraben, A., et al. (2016) Exploratory Phase II Trial to Evaluate the Safety and the Antiepileptic Effect of Pitolisant (BF2.649) in Refractory Partial Seizures, Given as Adjunctive Treatment During 3 Months. Clinical Neuropharmacology, 39, 188-193. [Google Scholar] [CrossRef] [PubMed]
[36] Wheless, J.W. (2008) History of the Ketogenic Diet. Epilepsia, 49, 3-5. [Google Scholar] [CrossRef] [PubMed]
[37] Freeman, J.M. and Kossoff, E.H. (2010) Ketosis and the Ketogenic Diet, 2010: Advances in Treating Epilepsy and Other Disorders. Advances in Pediatrics, 57, 315-329. [Google Scholar] [CrossRef] [PubMed]
[38] Mazzuferi, M., Kumar, G., van Eyll, J., Danis, B., Foerch, P. and Kaminski, R.M. (2013) Nrf2 Defense Pathway: Experimental Evidence for Its Protective Role in Epilepsy. Annals of Neurology, 74, 560-568. [Google Scholar] [CrossRef] [PubMed]
[39] Williams, R.S.B., Boison, D., Masino, S.A. and Rho, J.M. (2024) Mechanisms of Ketogenic Diet Action. In: Noebels, J.L., Avoli, M., Rogawski, M.A., Vezzani, A. and Delgado-Escueta, A.V., Eds., Jasper’s Basic Mechanisms of the Epilepsies, Oxford University Press, 1635-1666. [Google Scholar] [CrossRef] 
[40] Michael-Titus, A.T. and Priestley, J.V. (2014) Omega-3 Fatty Acids and Traumatic Neurological Injury: From Neuroprotection to Neuroplasticity? Trends in Neurosciences, 37, 30-38. [Google Scholar] [CrossRef] [PubMed]
[41] Rogawski, M.A., Löscher, W. and Rho, J.M. (2016) Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet. Cold Spring Harbor Perspectives in Medicine, 6, a022780. [Google Scholar] [CrossRef] [PubMed]
[42] Johnson, K.V.-A. and Foster, K.R. (2018) Why Does the Microbiome Affect Behaviour? Nature Reviews Microbiology, 16, 647-655. [Google Scholar] [CrossRef] [PubMed]
[43] Ding, M., Lang, Y., Shu, H., Shao, J. and Cui, L. (2021) Microbiota-Gut-Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics. Frontiers in Immunology, 12, Article 742449. [Google Scholar] [CrossRef] [PubMed]
[44] De Caro, C., Leo, A., Nesci, V., Ghelardini, C., di Cesare Mannelli, L., Striano, P., et al. (2019) Intestinal Inflammation Increases Convulsant Activity and Reduces Antiepileptic Drug Efficacy in a Mouse Model of Epilepsy. Scientific Reports, 9, Article No. 13983. [Google Scholar] [CrossRef] [PubMed]
[45] Dong, L., Zheng, Q., Cheng, Y., Zhou, M., Wang, M., Xu, J., et al. (2022) Gut Microbial Characteristics of Adult Patients with Epilepsy. Frontiers in Neuroscience, 16, Article 803538. [Google Scholar] [CrossRef] [PubMed]

为你推荐